In late October 2021, the Treatment Council (Behandlingsråd) published three topics chosen for developing the so-called major analyses (større analyser) in 2022. The selected topics include:
- Patient-centered diabetes technology;
- Hand-held focused ultrasound in emergency medicine;
- Artificial intelligence (AI) as decision support for colonoscopy.
The patient-centered diabetes technology topic will cover the use of diabetes technologies to measure and regulate blood sugar for adults with type 1 diabetes, including insulin pumps and glucose meters.
The hand-held focused ultrasound in emergency medicine topic will focus on the use of ultrasound in the emergency department, ambulance, and in acute-focused examinations - as well as an overview of the selection of portable devices.
The analysis of AI as decision support for colonoscopy will review the existing knowledge in the field and consequences of application, as well as an overview of the evidence base and the algorithm behind the AI technology.
Also, potentially a fourth topic (Intelligent beds for use in intensive care units) may be added to the Treatment Council's program for 2022. The final decision to include the above-mentioned topic will be made at the Treatment Council's meeting in December 2021.
The Treatment Council is a new body for assessing treatments and health technologies that became fully operational in late May 2021. The Treatment Council is expected to prepare 2-3 major analyses annually. The analyses are based on more fundamental topics concerning treatment regimens or approaches or organization of treatment. Based on the received proposals, the Board of the Danish Regions selects 2-3 analysis topics once a year, which constitute the Council's annual program for major analyses.
The full details in Danish can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.